Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T18:55:33.234Z.
Calculation as of: 2026-10-06T18:55:33.234Z.
Quote observation: 2026-10-06T18:51:21.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 76b909c1583fef9061a4d716d1bfa7e8c39158eca830282836b9decd9e758125
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
Akanda Corp.
Market Cap
$61819.00
EBITDA Yield
N/A
Market Cap
$30263.00
EBITDA Yield
N/A
| NAME | MARKET CAP | EBITDA YIELD |
|---|---|---|
| Akanda Corp. (AKAN) | $61819.00 | N/A |
| PRF Technologies Ltd. (PRFX)vs › | $70876.00 | N/A |
| Zhongchao Inc. (ZCMD)vs › | $31083.00 | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30263.00 | N/A |
| Psyence Biomedical Ltd. (PBM)vs › | $96215.00 | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $109777.00 | N/A |
| NewGenIvf Group Limited (NIVF)vs › | $5989.00 | N/A |
| SciSparc Ltd. (SPRC)vs › | $242924.00 | N/A |
| Virax Biolabs Group Limited (VRAX)vs › | $357350.00 | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | N/A |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
